Celltrion chairman’s remarks “contemplating the development of a vaccine for Corona 19,” the share price is 2%

Celltrion’s honorary chairman Seo Jeong-in said that he is thinking about developing a new coronavirus infection (Corona 19) vaccine, and the stock price is also drawing attention.

As of the 18th, Celltrion closed the transaction at 314,000 won, down 2.18% (7,000 won) from the previous day.

At the online press conference that day, Chairman Seo said, “Vaccines are currently dependent on foreign countries, but I think this is the homework for domestic vaccines to follow. However, the environment for clinical trials of domestic vaccines is becoming increasingly difficult, and the world is developing vaccines. It is not an easy step because of this. If Korea cannot secure sovereignty in vaccine technology, it can cause a U-turn at the end of the tunnel when a mutation comes out.”

Chairman Seo said, “As we can see that companies trying to do business do not sell drugs at manufacturing cost, we believe that domestic companies should have technological sovereignty to protect the people. The ability to make antibodies means that we can make antigens. “There is this, but if technology sovereignty becomes a problem in the future, we will be forced to enter the vaccine industry.”

“We have a method of replicating spikes through chocells of mRNA or adenovirus as it is, and we have been developing antigens. We are preparing to advance to vaccines beyond business,” he explained the company’s plans for the future.

In particular, he mentioned the suspicion of the clinical results of the Corona 19 antibody treatment’Rekironaju’.

Chairman Seo said, “There are a lot of stories about statistical significance. How can all the effects of reducing the virus and shortening the recovery period appearing in 300 people be accidental. How can drugs for pneumonia be ineffective in mild patients? “I refuted.

They also opened their mouths to concerns that ADE (ADE is a phenomenon in which a person who received an antibody or vaccine against the virus becomes more severe when infected with a mutant virus) may cause a reaction to become’poison’ in severely ill patients.

“The ADE phenomenon in which the viral symptoms intensify or the amount of virus increases due to the antibody is possible only when specific conditions are met. After developing a neutralizing antibody, a cell test was conducted, and as a result of discovering ADE side effects,” “No,” he drew.